Full-year net sales results were driven by the strength of the Seeds and Genomics segment, including a record year for the company’s soybean business.
Seeds and Genomics segment net sales were approximately $1.4 billion for the quarter. For the fiscal year, net sales for the Seeds and Genomics segment reached $10.7 billion.